Effect of rutin on pharmacokinetic modulation of diclofenac in rats

References

• Assali M, Shawahna R, Dayyeh S, et al. (2018). Dexamethasone-diclofenac loaded polylactide nanoparticles: preparation, release and anti-inflammatory activity. Eur J Pharm Sci 122:179–84.
   PubMed Web of Science ®Google Scholar
• Carbonaro M, Grant G. (2005). Absorption of quercetin and rutin in rat small intestine. Ann Nutr Metab 49:178–82.
   PubMed Web of Science ®Google Scholar
• Daly AK, Rettie AE, Fowler DM, Miners JO. (2017). Pharmacogenomics of CYP2C9: functional and clinical considerations. J Pers Med 8:1–31.
   PubMed Web of Science ®Google Scholar
• De Paz-Campos MA, Ortiz MI, Chavez PA, et al. (2014). Synergistic effect of the interaction between curcumin and diclofenac on the formalin test in rats. Phytomedicine 21:1543–8.
   PubMed Web of Science ®Google Scholar
• Dogra A, Bhatt S, Magotra A, et al. (2018). Intervention of curcumin on oral pharmacokinetics of daclatasvir in rat: a possible risk for long-term use. Phytother Res 32:1967–74.
   PubMed Web of Science ®Google Scholar
• Ekor M. (2014). The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 4:1–10.
   Web of Science ®Google Scholar
• Friend DR. (2004). Drug delivery to the small intestine. Curr Gastroenterol Rep 6:371–6.
   PubMedGoogle Scholar
• Ganeshpurkar A, Saluja AK. (2017). The pharmacological potential of rutin. Saudi Pharm J 25:149–64.
   PubMed Web of Science ®Google Scholar
• Graefe EU, Wittig J, Mueller S, et al. (2001). Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41:492–9.
   PubMed Web of Science ®Google Scholar
• Hisaka A, Nakamura M, Tsukihashi A, et al. (2014). Assessment of intestinal availability (FG) of substrate drugs of Cytochrome P450s by analyzing changes in pharmacokinetic properties caused by drug-drug interactions. Drug Metab Dispos 42:1640–5.
   PubMed Web of Science ®Google Scholar
• Jeong EJ, Liu Y, Lin H, and, Hu M. (2004). In situ single-pass perfused rat intestinal model for absorption and metabolism. In: Yan Z., Caldwell G.W. eds. Optimization in drug discovery. methods in pharmacology and toxicology. Totowa: Humana Press, 65–76.
   Google Scholar
• Lagas JS, Kruijssen C, Wetering KV, et al. (2009). Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone. Drug Metab Dispos 37:129–36.
   PubMed Web of Science ®Google Scholar
• Lindell M, Lang M, Lennernäs H. (2003). Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine; comparison to the liver . Eur J Drug Metab Pharmacokinet 28:41–8.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–8.
   PubMed Web of Science ®Google Scholar
• Mumuni M, Attzma AA, Kunle OO. (2016). Formulation in vitro and in vivo evaluation of SRMS-based heterolipid-templated homolipid delivery system for diclofenac sodium. Drug Deliv 23:1–9.
   PubMed Web of Science ®Google Scholar
• Nagare N, Damre A, Singh KS, et al. (2010). Determination of site of absorption of propranolol in rat gut using in situ single-pass intestinal perfusion. Indian J Pharm Sci 72:625–9.
   PubMed Web of Science ®Google Scholar
• Najar IA, Sharma SC, Singh G, et al. (2011). Involvement of P-glycoprotein and CYP 3A4 in the enhancement of etoposide bioavailability by a piperine analogue. Chem Biol Interact 190:84–90.
   PubMed Web of Science ®Google Scholar
• Odom DM, Mladsi DM, Saag KG, et al. (2014). Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews. Clin Ther 36:906–17.
   PubMed Web of Science ®Google Scholar
• Randhawa GK, Kullar JS, Rajkumar   (2011). Bioenhancers from mother nature and their applicability in modern medicine. Int J Appl Basic Med Res 1:5–10.
   PubMedGoogle Scholar
• Rastogi H, Jana S. (2014). Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome P450 activities. Phytother Res 28:1873–8.
   PubMed Web of Science ®Google Scholar
• Roizen JD, Levine MA. (2018). The role of genetic variation in CYP2R1, the principal vitamin D 25-hydroxylase, in vitamin D homeostasis. Vitamin D, Volume 2: Health, Disease and Therapeutics, 4th ed. Amsterdam: Elsevier.
   Google Scholar
• Sachin BS, Sharma SC, Sethi S, et al. (2007). Herbal modulation of drug bioavailability: enhancement of rifampicin levels in plasma by herbal products and a flavonoid glycoside derived from Cuminum cyminum. Phytother Res 21:157–63.
   PubMed Web of Science ®Google Scholar
• Shannon RS, Minakshi N, Nihal A. (2008). Dose translation from animal to human studies revisited. Faseb J 22:659–61.
   PubMed Web of Science ®Google Scholar
• Sharma A, Gour A, Bhatt S, et al. (2019). Effect of IS01957, a para-coumaric acid derivative on pharmacokinetic modulation of diclofenac through oral route for augmented efficacy. Drug Dev Res 80:948–57.
   PubMed Web of Science ®Google Scholar
• Sharma A, Magotra A, Bhatt S, et al. (2018). Potential herb-drug interaction of a flavone glycoside from Cuminum cyminum: Possible pathway for bioenhancement of rifampicin. Indian J Tradit Know 17:776–82.
   Web of Science ®Google Scholar
• Sharma A, Magotra A, Dogra A, et al. (2017). Pharmacokinetics, pharmacodynamics and safety profiling of IS01957, a preclinical candidate possessing dual activity against inflammation and nociception. Regul Toxicol Pharmacol 91:216–25.
   PubMed Web of Science ®Google Scholar
• Shimoi K, Yoshizumi K, Kido T, et al. (2003). Absorption and urinary excretion of quercetin, rutin, and alphaG-rutin, a water soluble flavonoid, in rats. J Agric Food Chem 51:2785–9.
   PubMed Web of Science ®Google Scholar
• Spitz S. (2013). Physicians should be cautious when prescribing diclofenac. CMAJ 185:470.
   PubMed Web of Science ®Google Scholar
• Srinivas NR. (2015). Recent trends in preclinical drug-drug interaction studies of flavonoids-Review of case studies, issues and perspectives. Phytother Res 29:1679–91.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Washio T, Suzuki N, et al. (2008). Characterization of gastrointestinal drug absorption in cynomolgus monkey. Mol Pharm 5:340–8.
   PubMed Web of Science ®Google Scholar
• Tatiraju DV, Bagade VB, Karambelkar PJ, Jadhav VM, et al. (2013). Natural bioenhancers: an overview. J Pharmacogn Phytochem 2:55–60.
   Google Scholar
• USFDA. (2020). Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers. U.S. Food and Drug Administration, Silver Spring, MD 20993.
   Google Scholar
• Vrolijk MF, Haenen G, Opperhuizen A, et al. (2015). The supplement-drug interaction of quercetin with tamsulosin on vasorelaxation. Eur J Pharmacol 746:132–7.
   PubMed Web of Science ®Google Scholar
• Wahajuddin M, Singh SP, Raju KSR, et al. (2012). Simultaneous determination of nine model compounds in permeability samples using RP-HPLC: Application to prove the cassette administration principle in single pass intestinal perfusion study in rats. J Pharm Biomed Anal 67–68:71–6.
   PubMed Web of Science ®Google Scholar
• Wallace JL, McKnight W, Reuter BK, Vergnolle N. (2000). NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119:706–14.
   PubMed Web of Science ®Google Scholar
• Willis JV, Kendall MJ, Flinn RM, et al. (1979). The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J CLin Pharmacol 16:405–10.
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Izumi S, Ide H, Ohyama Y. (2004). Identification of a novel rat microsomal vitamin D3 25-hydroxylase. J Biol Chem 279:22848–56.
   PubMed Web of Science ®Google Scholar
• Ye H, Sui D, Liu W, et al. (2019). Effects of CYP2C11 gene knockout on the pharmacokinetics and pharmacodynamics of warfarin in rats. Xenobiotica 49:1478–84.
   PubMed Web of Science ®Google Scholar
• Yu C-P, Wu P-P, Hou Y-C, et al. (2011). Quercetin and rutin reduced the bioavailability of cyclosporine from neoral, an immunosuppressant, through activating P-glycoprotein and CYP 3A4. J Agric Food Chem 59:4644–8.
   PubMed Web of Science ®Google Scholar